MedPath

常州华生制药有限公司

Ownership
-
Established
1996-03-25
Employees
-
Market Cap
-
Website
www.watsonpharma.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Simvastatin Tablets

Product Name
米希伦
Approval Number
国药准字H20010167
Approval Date
Aug 17, 2020
NMPA

Sodium Risedronate

Product Name
利塞膦酸钠
Approval Number
国药准字H20040390
Approval Date
Aug 17, 2020
NMPA

Trazodone Hydrochloride

Product Name
盐酸曲唑酮
Approval Number
国药准字H20030243
Approval Date
Aug 17, 2020
NMPA

Olanzapine Tablets

Product Name
悉敏
Approval Number
国药准字H20030512
Approval Date
Aug 17, 2020
NMPA

Gemfibrozil Tablets

Product Name
吉非罗齐胶囊
Approval Number
国药准字H19983187
Approval Date
Aug 17, 2020
NMPA

Zaleplon Tablets

Product Name
思威坦
Approval Number
国药准字H20040520
Approval Date
Aug 17, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H19983083
Approval Date
Aug 17, 2020
NMPA

Seratrodast Tablets

Product Name
麦须佳
Approval Number
国药准字H20031059
Approval Date
Aug 17, 2020
NMPA

Trazodone Hydrochloride Tablets

Product Name
每素玉
Approval Number
国药准字H20031077
Approval Date
Aug 17, 2020
NMPA

Fluoxetine Hydrochloride Capsules

Product Name
优克
Approval Number
国药准字H19980138
Approval Date
Aug 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.